Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (561-570 of 927) with videos related to

Pageof 93
Sort By:
Giornale Italiano Di Cardiologia (2006)|June 25, 2026
[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study]Antonina Giammanco, Rosanna Gambacurta, Ioanna Gouni-Berthold, et al.
The American Journal of Cardiology|April 13, 2011
Positive remodeling on coronary computed tomography as a marker for plaque vulnerability on virtual histology intravascular ultrasoundEleanore S J Kröner, Joella E van Velzen, Mark J Boogers, et al.
Journal of Lipid Research|September 6, 2015
Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9Sam J L van der Tuin, Susan Kühnast, Jimmy F P Berbée, et al.
International Journal of Cardiology|October 13, 2007
Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot studyAnho Liem, Anton P van de Woestijne, Erik Bruijns, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 10, 2012
Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formationMaryline Olivier, Michael W Tanck, Ruud Out, et al.
Journal of Clinical Lipidology|July 3, 2024
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES studyVera A Bittner, Gregory G Schwartz, Deepak L Bhatt, et al.
Journal of Lipid Research|March 26, 2026
Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL-clearance and regress atherosclerosis on atorvastatin backgroundJosé A Inia, Leo H Zhang, Nanda Keijzer, et al.
Atherosclerosis|January 1, 2008
High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variantsBernadette A C van Acker, Gert-Jan Botma, Aeilko H Zwinderman, et al.
Investigative Radiology|April 21, 2010
Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography to noninvasively assess in-stent restenosisFleur R de Graaf, Joanne D Schuijf, Joëlla E van Velzen, et al.
Plos One|July 12, 2013
TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formationJacco C Karper, Mark M Ewing, Margreet R de Vries, et al.
Pageof 93

Showing results (561-570 of 927) with videos related to

Sort By:
Pageof 93
Giornale Italiano Di Cardiologia (2006)|June 25, 2026
[Bempedoic acid in real-world clinical practice: baseline and 8-week data from the Italian prospective, non-interventional MILOS study]Antonina Giammanco, Rosanna Gambacurta, Ioanna Gouni-Berthold, et al.
The American Journal of Cardiology|April 13, 2011
Positive remodeling on coronary computed tomography as a marker for plaque vulnerability on virtual histology intravascular ultrasoundEleanore S J Kröner, Joella E van Velzen, Mark J Boogers, et al.
Journal of Lipid Research|September 6, 2015
Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9Sam J L van der Tuin, Susan Kühnast, Jimmy F P Berbée, et al.
International Journal of Cardiology|October 13, 2007
Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot studyAnho Liem, Anton P van de Woestijne, Erik Bruijns, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 10, 2012
Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formationMaryline Olivier, Michael W Tanck, Ruud Out, et al.
Journal of Clinical Lipidology|July 3, 2024
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES studyVera A Bittner, Gregory G Schwartz, Deepak L Bhatt, et al.
Journal of Lipid Research|March 26, 2026
Obicetrapib and ezetimibe enhance LDL receptor-mediated VLDL-clearance and regress atherosclerosis on atorvastatin backgroundJosé A Inia, Leo H Zhang, Nanda Keijzer, et al.
Atherosclerosis|January 1, 2008
High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variantsBernadette A C van Acker, Gert-Jan Botma, Aeilko H Zwinderman, et al.
Investigative Radiology|April 21, 2010
Diagnostic accuracy of 320-row multidetector computed tomography coronary angiography to noninvasively assess in-stent restenosisFleur R de Graaf, Joanne D Schuijf, Joëlla E van Velzen, et al.
Plos One|July 12, 2013
TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formationJacco C Karper, Mark M Ewing, Margreet R de Vries, et al.
Pageof 93